These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21919113)

  • 1. Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.
    Herrinton LJ; Curtis JR; Chen L; Liu L; Delzell E; Lewis JD; Solomon DH; Griffin MR; Ouellet-Hellstom R; Beukelman T; Grijalva CG; Haynes K; Kuriya B; Lii J; Mitchel E; Patkar N; Rassen J; Winthrop KL; Nourjah P; Saag KG
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1199-209. PubMed ID: 21919113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.
    Grijalva CG; Chen L; Delzell E; Baddley JW; Beukelman T; Winthrop KL; Griffin MR; Herrinton LJ; Liu L; Ouellet-Hellstrom R; Patkar NM; Solomon DH; Lewis JD; Xie F; Saag KG; Curtis JR
    JAMA; 2011 Dec; 306(21):2331-9. PubMed ID: 22056398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious infections among a large cohort of subjects with systemically treated psoriasis.
    Dobry AS; Quesenberry CP; Ray GT; Geier JL; Asgari MM
    J Am Acad Dermatol; 2017 Nov; 77(5):838-844. PubMed ID: 28917384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases.
    Kawai VK; Grijalva CG; Arbogast PG; Curtis JR; Solomon DH; Delzell E; Chen L; Ouellet-Hellstrom R; Herrinton L; Liu L; Mitchell EF; Stein CM; Griffin MR
    Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1085-94. PubMed ID: 23281339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations.
    Accortt NA; Chung JB; Bonafede M; Limone BL; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2085-2094. PubMed ID: 28790811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
    Borren NZ; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
    Shobha V; Chandrashekara S; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
    Int J Rheum Dis; 2019 Feb; 22(2):280-287. PubMed ID: 30168281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study.
    Desai RJ; Bateman BT; Huybrechts KF; Patorno E; Hernandez-Diaz S; Park Y; Dejene SZ; Cohen J; Mogun H; Kim SC
    BMJ; 2017 Mar; 356():j895. PubMed ID: 28264814
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis.
    Wu JJ; Pelletier C; Ung B; Tian M
    J Med Econ; 2019 Apr; 22(4):365-371. PubMed ID: 30652520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.
    Yun H; Xie F; Beyl RN; Chen L; Lewis JD; Saag KG; Curtis JR
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1526-1534. PubMed ID: 27813327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.
    Dusetzina SB; Mack CD; Stürmer T
    PLoS One; 2013; 8(5):e63973. PubMed ID: 23667693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care.
    Lapane KL; Spooner JJ; Mucha L; Straus WL
    J Am Geriatr Soc; 2001 May; 49(5):577-84. PubMed ID: 11380750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
    Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
    J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver cirrhosis in selected autoimmune diseases: a nationwide cohort study in Taiwan.
    Tung CH; Lai NS; Lu MC; Lee CC
    Rheumatol Int; 2016 Feb; 36(2):199-205. PubMed ID: 26408009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis risk with biologics by screening-guided preventive strategy in rheumatoid arthritis under intermediate tuberculosis burden.
    Shin A; Lee YJ; Lee EB; Song YW; Kim SC; Kang EH
    Rheumatology (Oxford); 2021 Jun; 60(6):2755-2764. PubMed ID: 33188421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Kalb RE; Fiorentino DF; Lebwohl MG; Toole J; Poulin Y; Cohen AD; Goyal K; Fakharzadeh S; Calabro S; Chevrier M; Langholff W; You Y; Leonardi CL
    JAMA Dermatol; 2015 Sep; 151(9):961-9. PubMed ID: 25970800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents.
    Aparasu RR; Chatterjee S; Mehta S; Chen H
    Med Care; 2012 Nov; 50(11):961-9. PubMed ID: 23047786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis from the FDA Adverse Event Reporting System (FAERS).
    Araujo AGS; Borba HHL; Tonin FS; Lenzi L; Venson R; Pontarolo R; Wiens A
    BioDrugs; 2018 Aug; 32(4):377-390. PubMed ID: 29873000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population.
    Doshi JA; Takeshita J; Pinto L; Li P; Yu X; Rao P; Viswanathan HN; Gelfand JM
    J Am Acad Dermatol; 2016 Jun; 74(6):1057-1065.e4. PubMed ID: 26946986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting conversion rates to Medicaid among new admissions to nursing homes.
    Mor V; Intrator O; Laliberte L
    Health Serv Res; 1993 Apr; 28(1):1-25. PubMed ID: 8463107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.